Eos Pharmaceuticals India Limited

Eos Pharmaceuticals India Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24232DL2008PLC186122 Incorporated 24 December 2008 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company pharma MSME · Micro
Revenue · FY 2022
₹55.13 Lakh
▼ 35% YoY
Net loss · FY 2022
₹17.02 Lakh
Net margin -30.9%
EBITDA · FY 2022
-₹9.24 Lakh
EBITDA margin -16.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹84.16 Lakh
Secured borrowings
Company age
18 yrs
Est. 2008
Employees · EPFO
2
Provident fund records

About Eos Pharmaceuticals India Limited

Data last updated:

Eos Pharmaceuticals India Limited is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 December 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PLC186122. Its GSTIN is 03AAHCA5267F1ZW (Punjab).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Acme Pharmaceuticals India Limited. It is led by directors including Vishal Nanda (Managing Director) and Bhushan Nanda.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M – 142 Vikas Puri, New Delhi, Delhi, India – 110018.

As per the financials filed for FY 2022, the company reported a revenue of ₹55.13 Lakh, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹17.02 Lakh (net margin -30.9%) and EBITDA of -₹9.24 Lakh (EBITDA margin -16.8%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years and 24% over five years.

The company has about 2 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹84.16 Lakh on record. Court records list 36 cases involving the company, including 35 filed by the company and 1 filed against it; 1 case is pending.

Eos Pharmaceuticals India Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-10-0022231). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232DL2008PLC186122
Registration Number 186122
Incorporation Date 24 December 2008
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-PB-10-0022231
Key People
Vishal Nanda Managing Director Bhushan Nanda Director Monika Nanda Director

Recognitions & Rankings of Eos Pharmaceuticals India

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-PB-10-0022231

Contact details

Eos Pharmaceuticals India Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    M – 142 Vikas Puri, New Delhi, Delhi, India – 110018
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Eos Pharmaceuticals India Limited, buy the company report.

Comprehensive company report
Eos Pharmaceuticals India Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Eos Pharmaceuticals India is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Eos Pharmaceuticals India Limited, buy the company report.

Financials of Eos Pharmaceuticals India Limited

FY 2025 filings available

Eos Pharmaceuticals India Limited reported revenue of ₹55.13 Lakh (down 35% YoY) for FY 2022.

Revenue · FY 2022
₹55.13 Lakh ▼ 35%
Net loss · FY 2022
₹17.02 Lakh margin -30.9%
EBITDA · FY 2022
-₹9.24 Lakh margin -16.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 35%
3 years · compounded
▼ 33%
5 years · compounded
▼ 24%
EBITDA CAGR growth
1 year
▼ 286%
3 years · compounded
▼ 52%
5 years · compounded
▼ 59%

Revenue has declined at a compounded annual rate (CAGR) of 24% over five years, including a 35% fall in the latest year. EBITDA fell 286% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations₹55.13 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹9.24 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹17.02 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin-16.8%
Net Profit Margin-30.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Eos Pharmaceuticals India Limited, buy the company report.

Board of directors of Eos Pharmaceuticals India Limited

Eos Pharmaceuticals India has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhushan NandaDirector24 Dec 200817 Years 10 MonthsCurrent
Vishal NandaManaging Director24 Dec 200817 Years 10 MonthsCurrent
Monika NandaDirector24 Dec 200817 Years 10 MonthsCurrent
View all directors

Auditor

Eos Pharmaceuticals India Limited is audited by KUMAR VARINDER & ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
KUMAR VARINDER & ASSOCIATESFY 2022026726N

Shareholding

The shareholding of Eos Pharmaceuticals India Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Eos Pharmaceuticals India Limited, buy the company report.

Charges & borrowings

Open charges
₹84.16 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.59 Cr
Capital Local Area Bank Limited₹0.25 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Jul 2020100362453Others₹9.16 LakhOpen
21 Jun 2017100121292Others₹35 LakhOpen
19 Jun 2017100121164Others₹15 LakhOpen
29 May 200910162140Capital Local Area Bank Limited₹25 LakhOpen

To see the full charge records of Eos Pharmaceuticals India Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Eos Pharmaceuticals India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Eos Pharmaceuticals India Limited has a workforce of 2 employees on its EPFO records as of Oct 2025, across 1 active EPFO establishment.

Employee count
2
Active EPFO establishments
1

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2025-262
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Eos Pharmaceuticals India Limited, buy the company report.

GST

Eos Pharmaceuticals India has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
03AAHCA5267F1ZWPunjabActive23 May 2018

To see the full GST registrations and return filing status of Eos Pharmaceuticals India Limited, buy the company report.

Recent activity

Eos Pharmaceuticals India Limited has 4 board changes on record since 2008: 3 appointments and 1 cessation. The latest: Vishal Nanda ceased to be Director on 29 Sep 2018.

AGM
Eos Pharmaceuticals India Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Eos Pharmaceuticals India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others amounted to Rs. 9.16 Lakh with Charge ID 100362453 was registered on 27 Jul 2020.
Ceased
Vishal Nanda ceased to be Director.
Charges
A charge with Others amounted to Rs. 35.00 Lakh with Charge ID 100121292 was registered on 21 Jun 2017.
Charges
A charge with Others amounted to Rs. 15.00 Lakh with Charge ID 100121164 was registered on 19 Jun 2017.
Charges
A charge with Capital Local Area Bank Limited of Rs. 25.00 Lakh registered on 29 May 2009 with Charge ID 10162140 was modified on 03 Oct 2013.
Charges
A charge with Capital Local Area Bank Limited amounted to Rs. 25.00 Lakh with Charge ID 10162140 was registered on 29 May 2009.
Appointed
Bhushan Nanda was appointed as Director.
Appointed
Monika Nanda was appointed as Director.
Appointed
Vishal Nanda was appointed as Managing Director.
Incorporation
24 Dec 2008
Eos Pharmaceuticals India Limited was registered on 24 Dec 2008 with Roc Delhi Ii & aged 17 years 10 months as per MCA records.

Frequently asked questions

Eos Pharmaceuticals India is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 December 2008 (18+ years old) and is registered under CIN U24232DL2008PLC186122.

Eos Pharmaceuticals India has 3 current directors:

The latest financial statements of Eos Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Eos Pharmaceuticals India is 03AAHCA5267F1ZW, registered in Punjab.

The CIN (Corporate Identification Number) of Eos Pharmaceuticals India is U24232DL2008PLC186122. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Eos Pharmaceuticals India has 36 court cases on record: 35 filed by the company and 1 filed against it. 1 is pending.

Eos Pharmaceuticals India was incorporated on 24 December 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.

Vishal Nanda ceased to be Director on 29 Sep 2018. Bhushan Nanda was appointed as Director on 24 Dec 2008. Monika Nanda was appointed as Director on 24 Dec 2008. Eos Pharmaceuticals India has 4 board changes on record in total.

Yes, Eos Pharmaceuticals India is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-10-0022231).

The registered office of Eos Pharmaceuticals India is at M – 142 Vikas Puri, New Delhi, Delhi, India – 110018.